Mar 12, 2018
D2 Consulting's New Training Program Positions Specialty Pharmacies for Sales Success
Feb 21, 2018
Diplomat Managing Rising Drug Costs to Support Patients
Feb 20, 2018
Prime Therapeutics Proves PBMs' Value: Delivers Negative Drug Trend in 2017
Feb 06, 2018
Express Scripts Reduces Employers' Annual Prescription Drug Spending Growth Rate to Historic Low in 2017
Feb 05, 2018
Therigy® Kicks Off 2018 With a New Bundle of Patient-Centered Therapy Management Products and Enhancements
Jan 17, 2018
CVS Health Launches New Transform Rheumatoid Arthritis Care(TM) Program to Improve Clinical Outcomes and Lower Pharmacy Costs
Jan 05, 2018
Diplomat Reaffirms 2017 Guidance, Provides Preliminary 2018 Outlook
Dec 20, 2017
Diplomat Completes Acquisition of LDI Integrated Pharmacy Services, Secures New Credit Facilities
Dec 15, 2017
Express Scripts Closes Acquisition Of eviCore; Companies Unite To Improve Healthcare For 100 Million Americans
Dec 12, 2017
Hospital and Healthcare Employers Confront Rising Cost of Prescription Drugs
Dec 07, 2017
Retail Drug Prices Increase More Than 50X Faster Than Inflation Rate
Nov 30, 2017
Large Employers Confront Rising Cost of Prescription Drugs
Nov 02, 2017
The global specialty generics market is expected to reach USD 174.9 billion by 2025
Oct 26, 2017
Asembia Partners with Acentrus Specialty to Offer Leading Specialty Pharmacy Technology Platform to Clients
Oct 18, 2017
Avella launches NurseConnect program to engage and support patients
Oct 17, 2017
Prime Therapeutics' Studies Examine Rheumatoid Arthritis Therapies and Total Cost
Oct 13, 2017
Prime Therapeutics Study Finds a Diabetes Drugs Value Based Insurance Design Improves Adherence, Doesn't Lower Total Cost of Care
Oct 12, 2017
Mid-Year Drug Trend: Prime held spending increases to 0.8% for commercial clients, generated negative trend for government program clients
Oct 10, 2017
Express Scripts to Acquire eviCore healthcare; Accelerates Company's Shift to Patient Benefit Management
Oct 09, 2017
Specialty Generics Market Size Worth $174.9 Billion by 2025: Grand View Research, Inc.